相关实验视频
Updated: Feb 5, 2026

08:45
A Visual Assay to Monitor T6SS-mediated Bacterial Competition
Published on: March 20, 2013
16.2K
细菌竞争:如何热线鞭毛体
Geoffrey B Severin1, Christopher M Waters1
1Department of Microbiology, Genetics, and Immunology, Michigan State University, East Lansing, MI 48824, USA.
Current biology : CB
|February 3, 2026
概括
土壤微生物使用效应分子来驱逐竞争对手. 这项研究揭示了一种新的机制,即一种微生物将分子转移到另一个微生物,通过绕过正常的基因调节来触发逃避反应.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 细菌的传播 细菌的传播
背景情况:
- 土壤微生物通过复杂的信号通路相互作用.
- 循环二-GMP是一个关键的第二信使,调节细菌的行为,包括运动性.
- 鞭毛细胞生物合成受到像循环二-GMP这样的第二信使的严格控制.
研究的目的:
- 阐明土壤微生物诱导竞争对手运动的机制.
- 为了研究效应器转位如何影响细菌基因调节.
- 了解循环二-GMP在调解微生物间竞争中的作用.
主要方法:
- 细菌共同培养实验.细菌共同培养实验.
- 转子体突变发生,以识别效应基因和受体基因.
- 定量PCR用于分析基因表达.
- 光显微镜观察细菌的行为.
主要成果:
- 一个特定的效应分子从一个土壤微生物转移到竞争对手.
- 受体微生物表现出增强的运动性,游离了捐赠者.
- 这种逃脱反应是由一种新的途径介导的,它绕过了法定循环二-GMP抑制鞭毛基因生物合成的途径.
- 确定参与效应器输出和受体反应的关键基因.
结论:
- 微生物间的效应物转移是土壤环境中竞争性排斥的有效策略.
- 一个新的信号通路存在,它取代了已建立的循环di-GMP监管网络.
- 了解这些机制可以提供对微生物社区动态和农业潜在应用的见解.
相关概念视频
Competition
24.8K
When organisms require the same limited resources within an environment, they may have to compete for them. Competition is a net-negative interaction. Even if two competing individuals or populations do not interact directly, the overall fitness of both competitors is lowered as a result of not having full access to the limited resource.
24.8K
Bacterial Transformation
60.0K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
60.0K
Bacterial Signaling
40.8K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
40.8K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
799
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
799
Bacterial RNA Polymerase
32.8K
Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
32.8K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.9K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.9K

